Cell therapy · FDA · US patients · 2030

Customized stem cell therapy for all US patients

A practical knowledge base for patients, clinicians and researchers: what FDA has approved, the evidence behind it, how the rules work, and what it would take to reach every US patient by 2030.

Who are you?

I am one of the

Patients & families

Find out what is proven, what is not, and how to spot an unsafe clinic.

I am one of the

Clinicians

Look up approved products by condition, the evidence behind them, and where to refer.

I am one of the

Researchers & sponsors

Work out your regulatory tier and plan the route to an approved product.

Where things stand (Nov 2026): FDA continues to act against clinics selling unapproved stem cell products. No FDA policy today lets a whole class of facility, such as urgent care, make or give customized cell therapies. The 2030 roadmap is a scenario, not FDA policy.

Explore